869586-86-7

Upstream product

• 1002557-03-0 2-chloro-4-(methylsulfanyl)benzonitrile 
• 60702-69-4 2-chloro-4-fluorobenzonitrile 
• 53250-83-2 2-chloro-4-(methanesulfonyl)benzoic acid 
• 869586-85-6 2-chloro-4-(methylsulfonyl)benzamide 

Downstream Products

• 869586-87-8 2-chloro-4-methylsulphonyl-N'-hydroxybenzenecarboximidamide 
• 869587-09-7 C₁₉H₂₄ClN₃O₇S 
• 869587-10-0 C₁₈H₂₂ClN₃O₇S 
• 869587-11-1 C₂₃H₃₀ClN₅O₇S 
• 869587-12-2 (3S)-1-[(2S)-2-[(tert-butoxycarbonyl)amino]-3-[3-[2-chloro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl]-1-oxohex-5-en-1-yl]-3-fluoropyrrolidine 

Relevant academic research and scientific papers

STAT DEGRADERS AND USES THEREOF

The present invention provides compounds, compositions thereof, and methods of using the same.

NEW COMPOUNDS I/418

There is provided compounds of formula I, wherein R1 to R7 have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.

1,2,4-OXADIAZOLE DERIVATIVES AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES

The present invention is directed to novel 1,2,4-oxadiazole derivatives which are inhibitors of the dipeptidyl peptidase-IV enzyme ("DP-IV inhibitors") and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.